Mather Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Buy
33,888
+17,652
+109% +$2.47M 0.05% 140
2025
Q4
$1.99M Buy
16,236
+2,837
+21% +$345K 0.02% 205
2025
Q3
$1.49M Sell
13,399
-116
-0.9% -$13.2K 0.02% 231
2025
Q2
$1.5M Sell
13,515
-73
-0.5% -$7.77K 0.02% 225
2025
Q1
$1.52M Buy
13,588
+6,731
+98% +$695K 0.02% 202
2024
Q4
$633K Sell
6,857
-802
-10% -$72.2K 0.01% 306
2024
Q3
$642K Sell
7,659
-5,498
-42% -$420K 0.01% 312
2024
Q2
$964K Buy
13,157
+2,556
+24% +$171K 0.01% 272
2024
Q1
$859K Sell
10,601
-1
-0% -$77 0.01% 246
2023
Q4
$859K Buy
10,602
+1,032
+11% +$80.3K 0.01% 251
2023
Q3
$717K Buy
9,570
+5
+0.1% +$385 0.01% 258
2023
Q2
$737K Sell
9,565
-4,464
-32% -$356K 0.01% 274
2023
Q1
$1.16M Buy
14,029
+5,026
+56% +$416K 0.02% 199
2022
Q4
$773K Buy
9,003
+131
+1% +$10.4K 0.01% 246
2022
Q3
$547K Buy
+8,872
New +$559K 0.01% 276

Other funds holding GILD

Mather Group's GILD Position: Q1 2026 in Review

Mather Group increased its Gilead Sciences (GILD) stake by 109% in Q1 2026, buying an estimated $2.47M and bringing the position to 33,888 shares worth $4.72M. The position accounts for 0.05% of the portfolio, ranked #140.

Mather Group first reported a position in GILD in Q3 2022 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Mather Group held 33,888 shares of Gilead Sciences worth $4.72M as of Q1 2026.
  • Mather Group bought 17,652 Gilead Sciences shares in Q1 2026, an estimated $2.47M.
  • Gilead Sciences made up 0.05% of Mather Group's portfolio in Q1 2026, its #140 holding.
  • Mather Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 15 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.